Non-randomized CNI group
Patients who agreed and were considered eligible to participate, but who were considered unsuitable at the screening visit or refused conversion to SRL were maintained on their CNI-based regimens at the previous target blood concentrations, but submitted to the same follow-up study visits. These patients composed the non-randomized control group (CNI group). The reasons for not converting to sirolimus were detailed in the 